(Q38403478)

English

Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.

scientific article published on 18 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

multicenter clinical trial

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

Stephen Nicholls

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

14

object named as

Steven E Nissen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

John J. P. Kastelein

7

object named as

John J P Kastelein

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Christie M. Ballantyne

4

object named as

Christie M Ballantyne

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Rishi Puri

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kathy Wolski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Philip J Barter

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

H Bryan Brewer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bo Hu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kiyoko Uno

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Yu Kataoka

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jean-Paul R Herrman

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bela Merkely

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Marilyn Borgman

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

American journal of cardiovascular drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

55-65

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of ACAT inhibition on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Factors underlying regression of coronary atheroma with potent statin therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

The forgotten majority: unfinished business in cardiovascular risk reduction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38403478&oldid=2201663453"